Inactivation of Stat3 in tumor cells: releasing a brake on immune responses against cancer?
A model of immune evasion mediated by tumors expressing constitutively activated Stat3 was recently proposed in Nature Medicine by Wang et al., suggesting opportunities for a new therapeutic approach for cancer.